Histogen Inc. Common Stock
HSTO
HSTO was delisted on the 4th of October, 2023.
22 hedge funds and large institutions have $988K invested in Histogen Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 7 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
8% less funds holding
Funds holding: 24 → 22 (-2)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
64% less capital invested
Capital invested by funds: $2.76M → $988K (-$1.78M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$130K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$39.3K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$15.8K |
| 4 |
SF
Synovus Financial
Columbus,
Georgia
|
+$7.59K |
| 5 |
Millennium Management
New York
|
+$3.34K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$1.64M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$17K |
| 3 |
VF
Virtu Financial
New York
|
-$11.3K |
| 4 |
Jane Street
New York
|
-$10K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Morgan Stanley
New York
| – | +$552 | +109 | New |
|
HSTO Hedge Fund Activity: Q1 2022 in Review
22 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q1 2022, worth a combined $988K — down 64% from $2.76M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of HSTO and 5 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 6 added.
The largest buyer was Renaissance Technologies, adding an estimated $130K. The largest seller was Armistice Capital, exiting entirely with an estimated $1.64M sold.
- 22 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q1 2022, down from 24 in Q4 2021.
- Funds reported $988K of Histogen Inc. Common Stock stock for Q1 2022, down 64% quarter-over-quarter.
- 5 funds opened new Histogen Inc. Common Stock positions in Q1 2022 and 7 closed out, a net change of -2 holders.
- The largest Histogen Inc. Common Stock buyer in Q1 2022 was Renaissance Technologies, an estimated $130K added.
- The largest Histogen Inc. Common Stock seller in Q1 2022 was Armistice Capital, an estimated $1.64M sold.
Based on aggregated 13F filings for Q1 2022.